Results
1 -
10 of
26
(Click
here to explore results)
- Drug Discovery for Leishmaniasis, Chapter 14 Nutrient Transport and Sensing as Pharmacological Targets for Leishmaniasis. Dan Zilberstein
, 2018
, Pages 282-296
- Drug Discovery for Leishmaniasis, Chapter 10 Organometallic Compounds in Chemotherapy Against Leishmania. Bruno Rodrigues do Prado, Arshad Islam, Frédéric Frézard, Cynthia Demicheli
, 2018
, Pages 199-223
- Neglected Diseases and Drug Discovery, Chapter 6 Drugs for Kinetoplastid Diseases – Current Situation and Challenges. Simon L. Croft
, 2012
, Pages 134-158
- Human Stem Cell Toxicology, Chapter 6 Current Developments in the Use of Human Stem Cell Derived Cardiomyocytes to Examine Drug-induced Cardiotoxicity. Varun Ahuja, Sharad Sharma, Raj Kamboj
, 2016
, Pages 124-159
- Drug Discovery for Leishmaniasis, Chapter 6 Omics and Their Impact on the Development of Chemotherapy Against Leishmania. Christopher Fernández-Prada, Isabel M. Vincent, Élodie Gazanion, Rubens L. Monte-Neto
, 2018
, Pages 101-129
- Drug Discovery for Leishmaniasis, I. Appraisal of Leishmaniasis Chemotherapy, Current Status and Pipeline StrategiesChapter 1 Leishmaniasis, Impact and Therapeutic Needs. Jorge Alvar, Byron Arana
, 2018
, Pages 1-23
- Molecularly Imprinted Polymers for Analytical Chemistry Applications, CHAPTER 12 Molecularly Imprinted Polymers: Providing Selectivity to Sample Preparation. Antonio Martín-Esteban
, 2018
, Pages 379-411
- New Horizons in Predictive Toxicology: Current Status and Application, Chapter 23 Toxicokinetics. Dennis A. Smith
, 2012
, Pages 599-618
- Drug Discovery for Leishmaniasis, Chapter 16 The Redox Metabolism and Oxidative Stress in Leishmania as a Crossroads for the Lethal Effect of Drugs. Helena Castro, Margarida Duarte, Ana M. Tomás
, 2018
, Pages 316-347
- Drug Discovery for Leishmaniasis, Subject Index
, 2018
, Pages 396-402